Dear Editor,

Multidrug resistance of *Pseudomonas aeruginosa* has been attributed to both intrinsic and acquired antibiotic-resistance mechanisms. Multidrug-resistant (MDR) *P. aeruginosa* isolates have become a serious healthcare problem worldwide because they are resistant to almost all β-lactams, aminoglycosides, and quinolones. Production of zinc-dependent metallo-β-lactamases (MBLs) has been identified as the most significant mechanism among carbapenem-resistant *P. aeruginosa* isolates \[[@B1]\]. MBLs are of particular clinical concern because of their broad-spectrum activities, and Imipenemase (IMP)-, Verona Integron-Encoded Metallo-β-lactamase (VIM)-, Sao Paulo metallo-β-lactamase (SPM)-, Germany imipenemase (GIM)-, and New Delhi Metallo-β-lactamase (NDM)-type MBLs have been identified in *P. aeruginosa* worldwide \[[@B2]\]. Forty-six variants of VIM enzymes have been identified to date (<http://www.lahey.org/Studies/other.asp>). VIM-38 was recently identified in *P. aeruginosa* isolates in Turkey and was shown to differ from VIM-5 by a single substitution (Ala316Val) \[[@B3]\]. In *P. aeruginosa*, VIM-type MBLs have been reported within mobile genetic elements such as integrons, which contribute to the dissemination of antibiotic resistance \[[@B3]\].

We here report a new clinical *P. aeruginosa* strain isolated from a blood sample on January 2015 at Rize State Hospital in Turkey and identified by using the API 32GN system (bioMerieux, Marcy-l\'Etoile, France). Minimal inhibitory concentrations were determined on a VITEK system for the following antibiotics: piperacillin/tazobactam, ceftazidime, cefepime, amikacin, netilmicin, ciprofloxacin, levofloxacin, imipenem, meropenem, cefoperazone-sulbactam, and inducible β-lactamase. 16S rDNA sequencing was used for molecular identification, performed according to Cicek et al \[[@B4]\].

The *P. aeruginosa* isolate was screened for β-lactamase-encoding genes and the class 1--class 2 integrases conserved region by PCR. The primers used for detection of β-lactamase-encoding genes and class 1 and class 2 integron gene cassettes are listed in [Table 1](#T1){ref-type="table"} \[[@B4][@B5][@B6][@B7][@B8]\].

The positive PCR product of the class 1 integron was cloned into pGEM-T easy vector (Promega, Madison, WI, USA) and then sequenced by Macrogen (Amsterdam, The Netherlands). Sequencing results were analyzed by using the BLAST alignment search tool (<http://www.ncbi.nlm.nih.gov/BLAST>) and the multiple sequence alignment program CLUSTALW2 (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>).

Transferability of antibiotic resistance was tested according to the previously defined protocol \[[@B9]\], by using the rifampin-resistant *Escherichia coli* K-12 strain J53-2 as a recipient \[[@B4]\]. Susceptibility testing of the MBL-producing integron-positive *P. aeruginosa* isolate showed that it was resistant to imipenem, meropenem, piperacillin/tazobactam, ceftazidime, cefepime, and cefoperazone-sulbactam. PCR analysis showed that the isolate did not harbor any of the antibiotic resistance genes listed in [Table 1](#T1){ref-type="table"}, except for *bla*~VIM~-type MBL. Sequence analysis of the *bla*~VIM~-variant identified it as *bla*~VIM-38~. The *P. aeruginosa* isolate contained a class 1 integron gene cassette, but not a class 2 integron gene cassette. The *bla*~VIM-38~-harboring class 1 integron gene cassette was sequenced and was found to be 3,239 bp long. DNA sequence analysis revealed that *bla*~VIM-38~ MBL was located on the class 1 integron gene cassette together with *AAC(6´)-Ib*/*EmrE*/*aadA1* ([Fig. 1](#F1){ref-type="fig"}). The conjugation assay revealed that the class 1 integron cassette is not transferable.

The *bla*~VIM-38~ gene was identified in *P. aeruginosa* isolates in Turkey in 2014, and found to be located in a class 1 integron containing only two gene cassettes (*bla*~VIM-38~/orfD) \[[@B3]\]. This genetic structure has also been associated with the *bla*~VIM-5~ gene in a clinical isolate of Enterobacter cloaceae from Turkey \[[@B9]\]. Moreover, steady-state kinetic analyses in a study on the enzymatic properties of VIM-38 showed that VIM-38 hydrolyzed all of the tested penicillins, cephalosporins, and carbapenems \[[@B10]\].

In the present study, the class 1 integron included four gene cassettes with *bla*~VIM-38~ followed by *AAC(6´)-Ib*, *EmrE* (multi-drug transporter), and *aadA1*. This is the first report in Turkey of the *bla*~VIM-38~/*AAC(6´)-Ib*/*EmrE*/*aadA1* gene cassette array. Therefore, we report a novel gene cassette array with an MBL gene in a *P. aeruginos*a clinical isolate, and this is the second report for the detection of VIM-38 in a *P. aeruginosa* isolate in Turkey with different hospitalization and isolation times.

In conclusion, the presence of class 1 integrons in *P. aeruginosa* leads to increased resistance to antibiotics. The present study demonstrates the emergence of VIM-producing MDR *P. aeruginosa* strains harboring class 1 integrons and a gene cassette in Turkey. In particular, the *bla*~VIM-38~ MBL gene appears to be spreading among *P. aeruginosa* isolates in Turkey.
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###### Primers used in the amplification of selected genes

![](alm-36-611-i001)

  Primers                     5\'→3\'                            Amplicon size   T~m~ (℃)
  --------------------------- ---------------------------------- --------------- ----------
  *bla*~TEM~                  F: AGTATTCAACATTTYCGTGT            847             56
  R: TAATCAGTGAGGCACCTATCTC                                                      
  *bla*~SHV~                  F: ATGCGTTATATTCGCCTGTG            843             55
  R: TTAGCGTTGCCAGTGCTC                                                          
  *bla*~CTX-M1~               F: GCGTGATACCACTTCACCTC            260             
  R: TGAAGTAAGTGACCAGAATC                                                        
  *bla*~CTX-M2~               F: TGATACCACCACGCCGCTC             341             
  R: TATTGCATCAGAAACCGTGGG                                                       
  *bla*~GES~                  F: ATGCGCTTCATTCACGCAC             863             056
  R: CTATTTGTCCGTGCTCAGGA                                                        
  *bla*~VEB~                  F: ATTTCCCGATGCAAAGCGT             542             55
  R: TTATTCCGGAAGTCCCTGT                                                         
  *bla*~PER-2~                F: ATGAATGTCATCACAAAATG            860             45
  R: ATAATAGCTTCATTGGTTC                                                         
  *bla*~KPC~                  F: ATGTCACTGTATCGCCGTCT            893             55
  R: TTTTCAGAGCCTTACTGCCC                                                        
  *bla*~IMP~                  F: CATGGTTTGGTGGTTCTTGT            488             56
  R: ATAATTTGGCGGACTTTGGC                                                        
  *bla*~VIM~                  F: ATTGGTCTATTTGACCGCGTC           780             58
  R: TGCTACTCAACGACTGAGCG                                                        
  *bla*~NDM~                  F: GAGATTGCCGAGCGACTTG             497             57
  R: CGAATGTCTGGCAGCACACTT                                                       
  *bla*~OXA-51~               F: TAATGCTTTGATCGGCCTTG            353             52
  R: TGGATTGCACTTCATCTTGG                                                        
  *bla*~OXA-23~               F: GATCGGATTGGAGAACCAGA            501             
  R: ATTTCTGACCGCATTTCCAT                                                        
  *bla*~OXA-40~               F: GGTTAGTTGGCCCCCTTAAA            246             
  R: AGTTGAGCGAAAAGGGGATT                                                        
  *bla*~OXA-58~               F: AAGTAT TGGGGCTTGTGCTG           599             
  R: CCCCTCTGCGCTCTACATAC                                                        
  *bla*~GIM-1~                F: TCGACACACCTTGGTCTG AA           477             
  R: AACTTCCAACTTTGCCATGC                                                        
  *bla*~SPM-1~                F: AAAATCTGGGTACGCAAACG            271             
  R: ACATTATCCGCTGGAACAGG                                                        
  *bla*~SIM-1~                F: TACAAGGGATTCGGCATC G            570             
  R: TAATGGCCT GTTCCCATGTG                                                       
  *bla*~CMY~                  F: GACAGCCTCTTTCTCCACA             1,000           50
  R: TGGAACGAAGGCTA CGTA                                                         
  5\'-CS                      F: GGCATCCAAGCAGCAAG                               56
  3\'-CS                      R: AAGCAGACTTGACCTGA                               
  hep51                       F: GATGCCATCGCAAGTACGAG                            55
  hep74                       R: CGGGATCCCGGACGGATGCACGATTTGTA                   

Abbreviations: Tm, melting temperature; CS, conserved segment of class-I integron; hep51, forward primer of of class-II integron; hep75, reverse primer of of class-II integron; CMY cephalomycinase coding gene.
